OQROGet OQRO Pro
Insider trade

Fulgent Genetics (FLGT)Chief Scientific Officer sold ~$23K

Hanlin Gao, Chief Scientific Officer at Fulgent Genetics, sold ~$23K of Fulgent Genetics shares.

~$23K
Approx. value · 1,063 sh @ $22.03
957K
Holds after · shares reported
Traded
Sep 3, 2025
Filed
Sep 3, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 25, 2025Insider · 2 peopleInsiders: 2 sales (~$27K)
  2. Aug 27, 2025Insider · 2 peopleInsiders: 2 sales (~$46K)
  3. Sep 3, 2025 · this disclosureInsiderOfficer sold ~$23K of FLGT shares in the open market

What came next

  1. Sep 3, 2025InsiderOfficer sold ~$25K of FLGT shares in the open market
  2. Nov 7, 2025Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  3. Dec 20, 2025Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Fulgent Genetics

For Fulgent Genetics, OQRO holds 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its FLGT page.

Other recent filings by Hanlin Gao, Chief Scientific Officer

The full history of Hanlin Gao, Chief Scientific Officer is on the profile page.

How this filing works

Other disclosures at Fulgent Genetics

Everything OQRO holds on this company is on its FLGT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data